Interleukin 17A promotes gastric cancer invasiveness via NF-κB mediated matrix metalloproteinases 2 and 9 expression

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Wang, Yidong ^a   Wu, Hong ^b   Wu, Xiaoling ^a   Bian, Zhuoqiong ^c   Gao, Qing ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^b Xi'an XD Group Hospital   (China)

^c The Fifth Hospital of Xi'an City   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; HELENALIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 17; PROTEIN P50; SYNAPTOTAGMIN I; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ARTICLE; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INDUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; STOMACH CANCER; STOMACH CARCINOGENESIS; TUMOR INVASION;

EID: 84902589077     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0096678     Document Type: Article

References (29)

1. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55(2): 74-108. (Pubitemid 40372904)
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61(2): 69-90.
3. Tan B, Li Y, Zhao Q, Fan L, Wang D, et al. (2013) Inhibition of gastric cancer cell growth and invasion through siRNA-mediated knockdown of guanine nucleotide exchange factor Vav3. Tumour Biol.
4. Rouvier E, Luciani MF, Mattei MG, Denizot F, Golstein P (1993) CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene. J Immunol 150(12): 5445-5456. (Pubitemid 23180658)
5. Li H, Chen J, Huang A, Stinson J, Heldens S, et al. (2000) Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family. Proc Natl Acad Sci U S A 97(2): 773-778. (Pubitemid 30070385)
6. Starnes T, Broxmeyer HE, Robertson MJ, Hromas R (2002) Cutting edge: IL-17D, a novel member of the IL-17 family, stimulates cytokine production and inhibits hemopoiesis. J Immunol 169(2): 642-646. (Pubitemid 34753417)
7. Lee J, Ho WH, Maruoka M, Corpuz RT, Baldwin DT, et al. (2001) IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1. J Biol Chem 276(2): 1660-1664. (Pubitemid 32096603)
8. Starnes T, Robertson MJ, Sledge G, Kelich S, Nakshatri H, et al. (2001) Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production. J Immunol 167(8): 4137-4140. (Pubitemid 32954284)
9. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420(6917): 860-867. (Pubitemid 36019639)
10. Lindholm C, Quiding-Jarbrink M, Lonroth H, Hamlet A, Svennerholm AM (1998) Local cytokine response in Helicobacter pylori-infected subjects. Infect Immun 66(12): 5964-5971. (Pubitemid 28531859)
11. Basso D, Scrigner M, Toma A, Navaglia F, Di Mario F, et al. (1996) Helicobacter pylori infection enhances mucosal interleukin-1 beta, interleukin-6, and the soluble receptor of interleukin-2. Int J Clin Lab Res 26(3): 207-210.
12. Zambon CF, Basso D, Navaglia F, Germano G, Gallo N, et al. (2002) Helicobacter pylori virulence genes and host IL-1RN and IL-1beta genes interplay in favouring the development of peptic ulcer and intestinal metaplasia. Cytokine 18(5): 242-251. (Pubitemid 35007484)
13. Holck S, Norgaard A, Bennedsen M, Permin H, Norn S, et al. (2003) Gastric mucosal cytokine responses in Helicobacter pylori-infected patients with gastritis and peptic ulcers. Association with inflammatory parameters and bacteria load. FEMS Immunol Med Microbiol 36(3): 175-180. (Pubitemid 36556036)
14. Cheng G, Wei L, Xiurong W, Xiangzhen L, Shiguang Z, et al. (2009) IL-17 stimulates migration of carotid artery vascular smooth muscle cells in an MMP-9 dependent manner via p38 MAPK and ERK1/2-dependent NF-kappaB and AP-1 activation. Cell Mol Neurobiol 29(8): 1161-1168.
15. Hus I, Bojarska-Junak A, Chocholska S, Tomczak W, Wos J, et al. (2013) Th17/IL-17A might play a protective role in chronic lymphocytic leukemia immunity. PLoS One 8(11): e78091.
16. Lu L, Pan K, Zheng HX, Li JJ, Qiu HJ, et al. (2013) IL-17A promotes immune cell recruitment in human esophageal cancers and the infiltrating dendritic cells represent a positive prognostic marker for patient survival. J Immunother 36(8): 451-458.
17. Li J, Lau GK, Chen L, Dong SS, Lan HY, et al. (2011) Interleukin 17A promotes hepatocellular carcinoma metastasis via NF-kB induced matrix metalloproteinases 2 and 9 expression. PLoS One 6(7): e21816.
18. Egeblad M, Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2(3): 161-174. (Pubitemid 37328786)
19. Folgueras AR, Pendas AM, Sanchez LM, Lopez-Otin C (2004) Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. Int J Dev Biol 48(5-6): 411-424. (Pubitemid 39360392)
20. Shalom-Barak T, Quach J, Lotz M (1998) Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF-kappaB. J Biol Chem 273(42): 27467-27473. (Pubitemid 28500465)
21. Doreau A, Belot A, Bastid J, Riche B, Trescol-Biemont MC, et al. (2009) Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus. Nat Immunol 10(7): 778-785.
22. Zhao L, Zhang C, Liao G, Long J (2010) RNAi-mediated inhibition of PDGF-D leads to decreased cell growth, invasion and angiogenesis in the SGC-7901 gastric cancer xenograft model. Cancer Biol Ther 9(1): 42-48.
23. Kotake S, Udagawa N, Takahashi N, Matsuzaki K, Itoh K, et al. (1999) IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 103(9): 1345-1352. (Pubitemid 29218305)
24. Axtell RC, de Jong BA, Boniface K, van der Voort LF, Bhat R, et al. (2010) T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis. Nat Med 16(4): 406-412.
25. Su X, Ye J, Hsueh EC, Zhang Y, Hoft DF, et al. (2010) Tumor microenvironments direct the recruitment and expansion of human Th17 cells. J Immunol 184(3): 1630-1641.
26. Zhu X, Mulcahy LA, Mohammed RA, Lee AH, Franks HA, et al. (2008) IL-17 expression by breast-cancer-associated macrophages: IL-17 promotes invasiveness of breast cancer cell lines. Breast Cancer Res 10(6): R95.
27. Chen JG, Xia JC, Liang XT, Pan K, Wang W, et al. (2011) Intratumoral expression of IL-17 and its prognostic role in gastric adenocarcinoma patients. Int J Biol Sci 7(1): 53-60.
28. Lavu H, Potluri V (2013) Proinflammatory T-helper 17 cells and interleukin 17 in gastric cancer. J Surg Res 185(2): 516-517.
29. Chen K, Zhang S, Ji Y, Li J, An P, et al. (2013) Baicalein inhibits the invasion and metastatic capabilities of hepatocellular carcinoma cells via down-regulation of the ERK pathway. PLoS One 8(9): e72927.